Categories: Wire Stories

Babcock & Wilcox Announces Agreement to Study Development of Biomass-to-Hydrogen Project in South Korea Using BrightLoop� Technology

AKRON, Ohio–(BUSINESS WIRE)–$BW #biomass–Babcock & Wilcox (B&W) (NYSE: BW) announced today that it has signed an agreement with NRG Korea to study the applicability of B&W�s BrightLoop™ technology for a hydrogen generation facility using biomass fuel in South Korea.

B&W’s BrightLoop chemical looping technology is part of its ClimateBright™ suite of decarbonization and hydrogen technologies. The BrightLoop process uses a proprietary, regenerable particle and has been demonstrated to effectively separate carbon dioxide (CO2) while producing hydrogen, steam and/or syngas, and is ready for commercial scale-up.

B&W and NRG have signed a memorandum of understanding to study the technology and potentially develop the project, which would use waste biomass as feedstock to produce hydrogen for fuel cells used for electrical generation.

“As the energy transition accelerates, clean hydrogen from net-carbon neutral sources will play an increasingly important role in energy generation,” said Joe Buckler, B&W Senior Vice President, Clean Energy. “B&W’s BrightLoop technology is a cutting-edge solution for hydrogen generation from virtually any fuel stock, and, depending on a customer’s needs, also can be used to isolate CO2 for capture or use, and produce steam or syngas. BrightLoop is a flexible solution with a wide array of potential applications.”

“We’re excited to have the opportunity to work closely with NRG to develop this groundbreaking clean energy project,” Buckler said.

Jay Kim, Chief Executive Officer of NRG Korea said, “NRG Korea is excited to be cooperating with Babcock & Wilcox, a world-renowned technology leader, in the development of this unique and innovative energy project. We see this project as a significant development in the renewable energy space by generating clean electrical power using green hydrogen produced from a renewable waste-based fuel.”

NRG Korea, established in 2008, is a Korean company specializing in waste processing and manufacture of alternative fuels and holds a number of patents related to their unique processing technologies.

B&W’s ClimateBright suite of revolutionary decarbonization technologies are designed to help utilities and industry aggressively combat greenhouse gas emissions and climate change. These technologies have application for a wide range of industries including energy production, food manufacturing, steel, cement, oil and gas, pharmaceutical, petrochemical, carbon black, and pulp and paper.

About Babcock & Wilcox

Headquartered in Akron, Ohio, Babcock & Wilcox Enterprises, Inc. is a leader in energy and environmental products and services for power and industrial markets worldwide. Follow us on LinkedIn and learn more at babcock.com.

Forward-Looking Statements

B&W cautions that this release contains forward-looking statements, including, without limitation, statements relating to the signing of a memorandum of understanding with NRG Korea to study the applicability of B&W’s BrightLoop technology for a biomass to hydrogen facility in South Korea. These forward-looking statements are based on management’s current expectations and involve a number of risks and uncertainties. For a more complete discussion of these risk factors, see our filings with the Securities and Exchange Commission, including our most recent annual report on Form 10-K. If one or more of these risks or other risks materialize, actual results may vary materially from those expressed. We caution readers not to place undue reliance on these forward-looking statements, which speak only as of the date of this release, and we undertake no obligation to update or revise any forward-looking statement, except to the extent required by applicable law.

Contacts

Investor Contact:
Investor Relations

Babcock & Wilcox

704.625.4944

investors@babcock.com

Media Contact:
Ryan Cornell

Public Relations

Babcock & Wilcox

330.860.1345

rscornell@babcock.com

Alex

Recent Posts

HighField Biopharmaceuticals ASCO 2024 Poster Presentation Shows HFK1, a Unique Immunoliposome May Improve Clinical Outcomes over Antibody Drug Conjugates

HFK1 is the company’s groundbreaking drug encapsulated immunoliposome for solid tumors with HER2 low expression…

25 mins ago

Bio-Sourcing and Partners Launch €3.4M EU Project in Inflammatory Indications with €1.9M EUREKA Eurostars Subsidies

AB-BIOBETTER to pioneer development of new oral formulation of adalimumab for inflammatory bowel diseases; offering…

26 mins ago

FOLLOWME TRADING CONTEST · MID-YEAR EVENT HONG KONG 2024 Concluded Spectacularly

HONG KONG SAR - Media OutReach Newswire - 28 May 2024 - On May 18th,…

42 mins ago

OPPO Teams Up with Global Brand Ambassador Kaká for Epic 2024 UEFA Champions League Final Celebrations

LONDON, UNITED KINGDOM - Media OutReach Newswire - 28 May 2024 - To celebrate this…

57 mins ago

The World’s First Pair of Nikkei 225 Leveraged & Inverse Products (L&Is) Outside of Japan to List on HKEX Tomorrow

HONG KONG--(BUSINESS WIRE)--Coupling with the first Nikkei 225 Index ETF (3153.HK) in Hong Kong, CSOP…

1 hour ago